Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Madan Jagasia

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Other

    VICCBMT16152

    03/27/2018

    Long Term Follow Up for Patients who have received Allogeneic Stem Cell Transplantation of NiCord?/CordIn, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells.

    Other

    VICCBMT1401

    08/29/2014

    Prospective Outcomes of Second-Line Therapy in Acute Graft-versus-Host Study Including ECP (POSTAGE)

    Treatment

    VICCBMT1760

    03/15/2018

    A Phase III Randomized Open-Label Multi-Center Study of Ruxolitinib vs. Best Available Therapy in Patients with Corticosteroid-Refractory Chronic Graft vs Host Disease after Allogenic Stem Cell Transplantation (REACH 3)

    Treatment

    VICCBMT1651

    09/30/2016

    Optimizing Post-Allogeneic Hematopoietic Cell Transplant Outcomes for Lymphoma Using Ibrutinib


    Print this page for your doctor